-
Je něco špatně v tomto záznamu ?
Variable expressivity of KMT2B variants at codon 2565 in patients with dystonia and developmental disorders
AM. Stehr, J. Fischer, N. Mirza-Schreiber, K. Bernardi, J. Porrmann, P. Harrer, F. Kaiser, RA. Jamra, J. Winkelmann, R. Jech, A. Koy, K. Oexle, M. Zech
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, kazuistiky
- MeSH
- dítě MeSH
- dospělí MeSH
- dystonické poruchy * genetika MeSH
- dystonie genetika MeSH
- histonlysin-N-methyltransferasa * genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- missense mutace MeSH
- mladiství MeSH
- mladý dospělý MeSH
- rodokmen * MeSH
- sekvenování exomu MeSH
- vývojové poruchy u dětí genetika MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
INTRODUCTION: Variable expressivity is an emerging characteristic of KMT2B-related dystonia. However, it remains poorly understood whether variants reoccurring at specific sites of lysine-specific methlytransferase-2B (KMT2B) can drive intra- and interfamilial clinical heterogeneity. Our goal was to ascertain independent families with variants affecting residue Arg2565 of KMT2B. METHODS: Whole-exome/genome sequencing, multi-site recruitment, genotype-phenotype correlations, and DNA methylation episignature analysis were performed. RESULTS: We report four individuals from two families harboring the variant c.7693C > G, p.Arg2565Gly. In an additional patient, a de-novo c.7693C > T, p.Arg2565Cys variant was identified. The observed phenotypic spectrum ranged from childhood-onset dystonia (N = 2) over unspecific intellectual disability syndromes (N = 2) to undiagnosed behavioral symptoms in adulthood (N = 1). Samples bearing p.Arg2565Gly had a KMT2B-typical episignature, although the effect on methylation was less pronounced than in carriers of loss-of-function KMT2B variants. CONCLUSIONS: We established the existence of a KMT2B missense-mutation hotspot associated with varying degrees of disease severity and expression, providing information for patient counseling and elucidation of pathomechanisms.
Department of Human Neurosciences Sapienza University of Rome Rome Italy
DZPG Deutsches Zentrum für Psychische Gesundheit Munich Germany
Institute for Advanced Study Technical University of Munich Garching Germany
Institute of Human Genetics Universitätsklinikum Essen Essen Germany
Institute of Human Genetics University of Leipzig Medical Center Leipzig Germany
Institute of Neurogenomics Helmholtz Zentrum München Munich Germany
Munich Cluster for Systems Neurology Munich Germany
Neurogenetic Systems Analysis Group Institute of Neurogenomics Helmholtz Munich Neuherberg Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009348
- 003
- CZ-PrNML
- 005
- 20250429134906.0
- 007
- ta
- 008
- 250415e20250205enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.parkreldis.2025.107319 $2 doi
- 035 __
- $a (PubMed)39933316
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Stehr, Antonia M $u Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany
- 245 10
- $a Variable expressivity of KMT2B variants at codon 2565 in patients with dystonia and developmental disorders / $c AM. Stehr, J. Fischer, N. Mirza-Schreiber, K. Bernardi, J. Porrmann, P. Harrer, F. Kaiser, RA. Jamra, J. Winkelmann, R. Jech, A. Koy, K. Oexle, M. Zech
- 520 9_
- $a INTRODUCTION: Variable expressivity is an emerging characteristic of KMT2B-related dystonia. However, it remains poorly understood whether variants reoccurring at specific sites of lysine-specific methlytransferase-2B (KMT2B) can drive intra- and interfamilial clinical heterogeneity. Our goal was to ascertain independent families with variants affecting residue Arg2565 of KMT2B. METHODS: Whole-exome/genome sequencing, multi-site recruitment, genotype-phenotype correlations, and DNA methylation episignature analysis were performed. RESULTS: We report four individuals from two families harboring the variant c.7693C > G, p.Arg2565Gly. In an additional patient, a de-novo c.7693C > T, p.Arg2565Cys variant was identified. The observed phenotypic spectrum ranged from childhood-onset dystonia (N = 2) over unspecific intellectual disability syndromes (N = 2) to undiagnosed behavioral symptoms in adulthood (N = 1). Samples bearing p.Arg2565Gly had a KMT2B-typical episignature, although the effect on methylation was less pronounced than in carriers of loss-of-function KMT2B variants. CONCLUSIONS: We established the existence of a KMT2B missense-mutation hotspot associated with varying degrees of disease severity and expression, providing information for patient counseling and elucidation of pathomechanisms.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a histonlysin-N-methyltransferasa $x genetika $7 D011495
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a rodokmen $7 D010375
- 650 12
- $a dystonické poruchy $x genetika $7 D020821
- 650 _2
- $a vývojové poruchy u dětí $x genetika $7 D002658
- 650 _2
- $a missense mutace $7 D020125
- 650 _2
- $a dystonie $x genetika $7 D004421
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a sekvenování exomu $7 D000073359
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Fischer, Jan $u Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology, Dresden, Germany
- 700 1_
- $a Mirza-Schreiber, Nazanin $u Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany; Neurogenetic Systems Analysis Group, Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany
- 700 1_
- $a Bernardi, Katerina $u Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
- 700 1_
- $a Porrmann, Joseph $u Institute for Clinical Genetics, University Hospital Carl Gustav Carus at TUD Dresden University of Technology, Dresden, Germany
- 700 1_
- $a Harrer, Philip $u Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany
- 700 1_
- $a Kaiser, Frank $u Institute of Human Genetics, Universitätsklinikum Essen, Essen, Germany
- 700 1_
- $a Jamra, Rami Abou $u Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany
- 700 1_
- $a Winkelmann, Juliane $u Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; DZPG, Deutsches Zentrum für Psychische Gesundheit, Munich, Germany
- 700 1_
- $a Jech, Robert $u Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Koy, Anne $u Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Rare Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
- 700 1_
- $a Oexle, Konrad $u Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany; Neurogenetic Systems Analysis Group, Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany
- 700 1_
- $a Zech, Michael $u Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany; Institute for Advanced Study, Technical University of Munich, Garching, Germany. Electronic address: michael.zech@mri.tum.de
- 773 0_
- $w MED00006198 $t Parkinsonism & related disorders $x 1873-5126 $g Roč. 133 (20250205), s. 107319
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39933316 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134901 $b ABA008
- 999 __
- $a ok $b bmc $g 2310994 $s 1246429
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 133 $c - $d 107319 $e 20250205 $i 1873-5126 $m Parkinsonism & related disorders $n Parkinsonism Relat Disord $x MED00006198
- LZP __
- $a Pubmed-20250415